Introduction to 2016 Wmif Disruptive Dozen 2
Let's dive into the details surrounding 2016 Wmif Disruptive Dozen 2. Immune Modulators (Checkpoint Inhibitors) and Vaccines Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical ...
2016 Wmif Disruptive Dozen 2 Comprehensive Overview
Cellular Immunotherapy Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter D. Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of Surgery, Harvard Medical School ... 2
1: Early Diagnosis and Treatment of Alzheimer's Disease Leading CNS faculty from the Brigham and Women's Hospital, ...
Summary & Highlights for 2016 Wmif Disruptive Dozen 2
- Patient-Specific Research to Enable Efficient Drug Development Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer ...
- Epigenetics and Cancer Treatment Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J.
- Machine Learning and Computational Biology to Transform Cancer Care Introduction by: Daniel Haber, MD, PhD, Director, MGH ...
- The Microbiome and Cancer Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ...
- CRISPR: Genome Editing and Cancer Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J.
That wraps up our extensive overview of 2016 Wmif Disruptive Dozen 2.